Managed Health Care Connect March 25, 2021
Amy Amick, president and chief executive officer, SPH Analytics

Health Risk Assessments (HRAs) arm employers and payers with the meaty consumer health data they need to assess individual health status, prioritize engagement and to motivate behavior change. Historically, HRAs were leveraged to aggregate data, predict outcomes and costs and drive targeted engagement.

Yet no risk assessment in the world could have predicted that COVID-19 would wield such a huge impact on all patients, from the sickest to the healthiest. The coronavirus pandemic has led to more than 400,000 deaths in the United States alone, and a wide array of clinical and behavioral complications for survivors. It’s thrown a wrench into preventive care and as a result, clinical outcomes.

Within the framework of the pandemic, these risk assessments are...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Patient / Consumer, Population Health Mgmt, Provider
Smartwatches reveal insights into psychiatric illnesses and genetic links
Digital therapeutics: Exploring the road to commercialization across international markets
B2C2B models gaining traction in HealthTech
Are popular weight loss drugs putting your patients at risk?
How are employers going to pay for cell and gene therapies?

Share This Article